Glipizide Tablet, Film Coated, Extended Release
Product Images NDC 64980-280

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 64980-280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural-formula (Structural Formula)

Chemical structure diagram of Glipizide, showing the molecular arrangement of its atoms including rings, sulfonyl, amide, and methyl functional groups.*

FDA Label Image

Rising Logo (Rising Logo)

FDA Label Image

Label-2.5mg-t10 (Label 2.5mg T10)

The label for Glipizide Extended-Release Tablets, USP displays a strength of 2.5 mg and is coated, extended-release oral tablets. The package contains 30 tablets. The labeler is Rising Pharma Holdings, Inc. The label includes usage instructions, storage conditions, and child-resistant container warnings, along with a barcode and manufacturer information for Unique Pharmaceuticals.*

FDA Label Image

Label-2.5mg-t20 (Label 2.5mg T20)

Glipizide Extended-Release Tablets USP 2.5 mg film-coated tablets, oral dosage form, supplied in a package of 30 tablets. The label from Rising Pharmaceuticals includes dosing and storage instructions along with manufacturer and distributor information. Product is Rx only.*

FDA Label Image

Label-5mg-t10 (Label 5mg T10)

Label for glipiZIDE Extended-Release Tablets, USP 5 mg by Rising Pharmaceuticals. The film-coated extended-release tablets provide a 5 mg dose of glipizide. The package contains 100 tablets. Storage instructions advise protecting the drug from moisture and humidity, storing at 20 to 25°C, and keeping out of reach of children. The label includes manufacturer and distributor information along with a barcode.*

FDA Label Image

Label-5mg-t20 (Label 5mg T20)

Label for Glipizide Extended-Release Tablets, USP 5 mg by Rising Pharmaceuticals. The film-coated extended-release tablets come in a bottle of 100 count. The label includes dosing guidance, storage instructions to protect from moisture and humidity, and a note that the product is Rx only. Manufacturer and distributor details are also provided along with an NDC barcode.*

FDA Label Image

Label-10mg-t10 (Label 10mg T10)

Glipizide Extended-Release Tablets USP 10 mg film-coated tablets packaging label. The label shows the product strength as 10 mg and indicates 100 tablets per container. Distributed by Rising Pharma Holdings, Inc., East Brunswick, NJ, and manufactured by Unique Pharmaceutical Laboratories, Mumbai, India. Storage instructions and barcode are also displayed.*

FDA Label Image

Label-10mg-t20 (Label 10mg T20)

Glipizide 10 mg extended-release tablets, USP, film-coated, oral dosage form in a package containing 100 tablets. Label includes storage instructions to keep tablets between 20° and 25°C and a note for pharmacists to dispense the patient information leaflet. Distributed by Rising Pharma Holdings, Inc., East Brunswick, NJ, and manufactured by Unique Pharmaceutical Laboratories, Mumbai, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.